Skip to main content
Browse by:

Pathology Grand Rounds - Updates from the 2020 WHO 5th Edition Classification of Female Genital Tumors

Event Image
Icon calendar
Friday, July 30, 2021
Icon time
12:00 pm - 1:00 pm
Icon location
Icon speaker
Lori Renee Scanga, MD, PhD, The University of North Carolina at Chapel Hill
Icon series
Pathology Grand Rounds

At the conclusion of this activity, learners should be able to:

* Understand ICD-O coding (International Classification of Diseases for Oncology)

* Know the recommended terminology for ovarian serous borderline tumors with micropapillary/cribriform pattern feedback

* Know the new molecular classification of endometrioid endometrial carcinoma

* Know the new classification of lower female genital tract (cervix, vagina, and vulva) precursor lesions, squamous cell carcinomas, and adenocarcinomas by HPV etiology (HPV-Associated and HPV-Independent)

* Know about newly described mutations and their associations in gynecologic cancer: SWI/SNF complex mutations including various SMARC deficient tumors, high grade endometrial stromal sarcoma with BCOR genetic abnormalities , NTRK-rearranged spindle cell neoplasm, TFE3 translocation associated PEComa, and Fumarate hydratase-deficient leiomyoma associated with Hereditary leiomyomatosis and Renal cell carcinoma (HLRCC syndrome)